Applications of CRISPR technology in cellular immunotherapy.
Published In: Immunological Reviews, 2023, v. 320, n. 1. P. 199 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: Zhou, Xiaoyu; Renauer, Paul A.; Zhou, Liqun; Fang, Shao‐Yu; Chen, Sidi 3 of 3
Abstract
Summary: CRISPR technology has transformed multiple fields, including cancer and immunology. CRISPR‐based gene editing and screening empowers direct genomic manipulation of immune cells, opening doors to unbiased functional genetic screens. These screens aid in the discovery of novel factors that regulate and reprogram immune responses, offering novel drug targets. The engineering of immune cells using CRISPR has sparked a transformation in the cellular immunotherapy field, resulting in a multitude of ongoing clinical trials. In this review, we discuss the development and applications of CRISPR and related gene editing technologies in immune cells, focusing on functional genomics screening, gene editing‐based cell therapies, as well as future directions in this rapidly advancing field. [ABSTRACT FROM AUTHOR]
Additional Information
- Source:Immunological Reviews. 2023/11, Vol. 320, Issue 1, p199
- Document Type:Article
- Subject Area:Biotechnology
- Publication Date:2023
- ISSN:0105-2896
- DOI:10.1111/imr.13241
- Accession Number:173777593
- Copyright Statement:Copyright of Immunological Reviews is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.